U.S. Water Utilities Stock News

As the U.S. stock market experiences a significant upswing, with major indexes like the Nasdaq and S&P 500 posting notable gains, investors are keenly observing growth companies that exhibit strong insider ownership. In such a buoyant market environment, stocks where company insiders hold substantial stakes can be appealing as they often signal confidence in the company's future prospects and alignment of interests with shareholders.

As the U.S. stock market continues its upward trajectory, with major indexes marking their biggest weekly rise since June, investors are increasingly exploring diverse opportunities to capitalize on this momentum. Penny stocks, a term that may seem outdated yet remains significant, represent smaller or newer companies that can potentially offer substantial returns when they are built on solid financial foundations. In this article, we will explore three penny stocks that exhibit strong...

As major U.S. stock indices, including the Dow Jones, Nasdaq, and S&P 500, continue to experience gains entering the Thanksgiving holiday week, investors are keenly observing market dynamics that could impact small-cap stocks. With economic indicators showing mixed signals and broader market sentiment fluctuating, identifying promising yet lesser-known stocks becomes crucial for those looking to capitalize on potential opportunities in a dynamic environment.

As the U.S. stock market experiences a notable upswing, with major indices like the Dow Jones, S&P 500, and Nasdaq showing significant gains entering the Thanksgiving holiday, investors are increasingly eyeing opportunities for stable income amid this positive momentum. In such an environment, dividend stocks can offer a reliable source of income through regular payouts while potentially benefiting from capital appreciation as markets rise.

Taiho Oncology, Taiho Pharmaceutical, and Cullinan Therapeutics recently announced the initiation of a rolling New Drug Application submission to the U.S. FDA for accelerated approval of zipalertinib, targeting EGFR exon 20 insertion-mutated non-small cell lung cancer after chemotherapy. This milestone builds on zipalertinib’s Breakthrough Therapy Designation and leverages data from the REZILIENT1 Phase 1/2 trial involving previously treated patients. We'll explore how progress toward FDA...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Six Flags Entertainment Corporation has announced the appointment of John Reilly as its new Chief Executive Officer and President, effective December 8, 2025, following a comprehensive board-led succession process. This leadership transition brings industry veteran Reilly to the helm as the company seeks to address recent operational challenges and has gained support from major shareholders, including activist investor JANA Partners. We’ll examine how John Reilly’s operational expertise and...

Oruka Therapeutics reported encouraging phase 1 results for its psoriasis drug candidate, ORKA-001. The data suggest a long half-life and strong, sustained inhibition of STAT3 signaling, along with a favorable safety profile. See our latest analysis for Oruka Therapeutics. These encouraging trial results have energized investor sentiment, fueling a 99.87% share price return over the past 90 days and lifting the stock to $30.52. Momentum has clearly been building, with a total shareholder...

iQIYI, Inc. recently announced its third-quarter 2025 results, reporting revenue of CNY 6,682.39 million, down from CNY 7,245.68 million a year earlier, and a net loss of CNY 248.93 million compared to net income of CNY 229.41 million in the same period last year. This marks a reversal from profitability to loss, highlighting the company's increased vulnerability to weaker content cycles and ongoing economic pressures in China. We’ll now assess how iQIYI’s swing to net loss and lower revenue...

Hanesbrands (HBI) recently posted modest gains, with shares ticking up about 1% over the past week. Investors are weighing the company's mixed fundamentals as the consumer durables sector undergoes shifts and retail demand trends continue to evolve. See our latest analysis for Hanesbrands. Hanesbrands has seen its share price rebound slightly over the past quarter, but momentum remains mixed after a tough year, with a 1-year total shareholder return of -25.11%. While short bursts of optimism...

It's easy to match the overall market return by buying an index fund. While individual stocks can be big winners...

To the annoyance of some shareholders, Here Group Limited ( NASDAQ:HERE ) shares are down a considerable 29% in the...

Xenon Pharmaceuticals recently announced plans to present seven posters at the upcoming American Epilepsy Society Annual Meeting, featuring long-term clinical and preclinical results for its epilepsy drug azetukalner and updates on its NaV1.1 research targeting Dravet syndrome. Among the highlights, the data will provide insights into long-term seizure-freedom, patient-reported depression, and new preclinical findings on seizure prevention and SUDEP risk reduction in animal models. We'll...

Kanzhun (NasdaqGS:BZ) just released its third quarter results, reporting sharp increases in revenue and net income compared to a year ago. The company also issued guidance projecting double-digit revenue growth for the next quarter. See our latest analysis for Kanzhun. Kanzhun’s upbeat quarterly results come as its stock has been on a tear in 2024, with a year-to-date share price return of nearly 60%. When reinvested dividends are factored in, the one-year total shareholder return increases...

Revvity (RVTY) shares have moved slightly higher this week, prompting some investors to take a closer look at recent performance. Over the past month, the stock has gained 7%, and the company’s annual revenue growth continues. See our latest analysis for Revvity. After a choppy start to the year, Revvity’s momentum has picked up noticeably. The share price has gained nearly 19% over the past quarter, even as the total shareholder return sits at -8% for the past 12 months. This suggests...

The board of Halliburton Company ( NYSE:HAL ) has announced that it will pay a dividend on the 24th of December, with...

Intuitive Machines, Inc. ( NASDAQ:LUNR ) shares have retraced a considerable 27% in the last month, reversing a fair...

Pony AI (NasdaqGS:PONY) has sparked fresh interest following a string of important events. These include a new Bolt partnership for European expansion, breakthroughs in its Gen-7 Robotaxi fleet, and a major Hong Kong dual listing that raised more capital. See our latest analysis for Pony AI. Momentum is building around Pony AI, with breakthroughs in both its robotaxi services and new partnerships fueling optimism despite some recent turbulence. After a steep 27.8% drop in its 30-day share...

In the past week, Aramark reported fourth quarter and full-year 2025 financial results showing annual sales of US$18.51 billion and net income of US$326.39 million, announced a 14% increase in its quarterly dividend, provided 2026 revenue guidance, and unveiled its SeniorLife+ Consultative Services program for senior living communities. This rollout of advanced AI-enabled facility management technology, combined with positive financial and operational updates, signals Aramark's focus on...

Hillman Solutions Corp. ( NASDAQ:HLMN ), might not be a large cap stock, but it saw significant share price movement...

Curious if Omnicell might be a hidden gem or just fairly priced? You're not alone; valuation is often top of mind for investors searching for opportunity. The stock has made some noise recently, jumping 7.5% over the past week and 19.0% in the last month, but it is still down 16.5% for the year and nearly 65% over five years. Recent headlines have focused on Omnicell’s strategic moves and ongoing efforts to boost operational efficiency, which has put the company back in the spotlight...

Danaos Corporation recently increased its quarterly dividend to US$0.90 per share and reported third quarter sales of US$260.73 million with net income of US$130.65 million, both higher than the same period last year. This combination of a dividend boost and improved quarterly financial results offers shareholders both immediate returns and signs of ongoing profitability. We'll examine how Danaos's dividend increase and stronger quarterly earnings could reshape its investment narrative and...

Key Insights Institutions' substantial holdings in Cadiz implies that they have significant influence over the...

As the U.S. stock market experiences a notable upswing, with major indices like the Dow Jones and S&P 500 posting significant gains, investors are closely watching how economic data and potential interest rate cuts might influence high-growth sectors such as technology. In this dynamic environment, identifying promising tech stocks involves assessing their ability to innovate and adapt amid shifting consumer trends and economic indicators.